Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes

Dear Colleagues,

We are pleased to invite you to contribute to this Special Issue of Pharmaceuticals, entitled “Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes”.

The increasing prevalence of chronic diseases has become one of the most important public health problems worldwide. Chronic diseases are associated with increased medication use and complex drug regimens. High medication use leads to polymedication, which is strongly associated with non-adherence and a reduced quality of life. Meanwhile, non-adherence has negative impacts in relation to clinical outcomes, such as furthering disease progression and increasing mortality, as well as in the form of rising healthcare costs.

To address these issues and improve chronic disease outcomes, methods to measure medication adherence must be implemented in daily clinical practice. The early identification of non-adherent patients will allow strategies to be implemented, to ensure the effectiveness of prescribed medications.

This Special Issue will showcase innovative research on improving medication adherence, highlighting possible new approaches to developing personalized therapeutic strategies for chronic diseases. For this Special Issue, submissions of original research articles and reviews are welcome. The selected set of manuscripts will be published as a Special Issue of Pharmaceuticals.

We look forward to receiving your contributions.

Dr. Eduardo Gutiérrez-Abejón
Prof. Dr. F. Javier Alvarez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.